Skip to main content

Cancer Research

Potential prostate cancer biomarkers

Sep. 19, 2019—An analysis of more than 140,000 people of European ancestry has identified blood protein biomarkers associated with prostate cancer risk.

Read more


Study identifies critical regulator of tumor-specific T cell differentiation

Jun. 18, 2019—A study published June 17 in Nature offers clues as to why blocking inhibitory receptors on tumor-infiltrating T cells may not always work

Read more


Discovery aids search for cancer biomarkers

Apr. 12, 2019—A report by researchers at Vanderbilt University Medical Center has shattered conventional wisdom about how cells, including cancer cells, shed DNA into the bloodstream.

Read more


Study shows magnesium optimizes vitamin D status

Dec. 19, 2018—A randomized trial by Vanderbilt-Ingram Cancer Center researchers indicates that magnesium optimizes vitamin D status, raising it in people with deficient levels and lowering it in people with high levels.

Read more


Limited submission opportunity: V Foundation 2018 Translational Research Awards

Mar. 2, 2018—Vanderbilt (VU + VUMC, collaboratively) anticipates the opportunity to choose one nominee for the V Foundation 2018 Translational Research Award.

Read more


Pancreatic cancer development

Aug. 31, 2017—Elevated levels of the factor G-CSF appear to promote the development of aggressive pancreatic cancer, suggesting a new therapeutic approach for this devastating disease.

Read more


Alex’s Lemonade grant allows new engineering grad student to join neuroblastoma fight

Jul. 5, 2017—Graduate student Kyle Garland is diving into his studies with eight weeks of intense immunology research.

Read more


Study examines new breast cancer drug combination

Apr. 20, 2017—A study led by Vanderbilt-Ingram Cancer Center (VICC) investigators suggests a drug combination which includes a PDK1 protein blocker may be more effective for breast cancer that has become resistant to cyclin-dependent kinase (CDK4/6) targeted therapy.

Read more


V Foundation grants bolster cancer initiatives

Nov. 17, 2016—Two Vanderbilt-Ingram Cancer Center (VICC) investigators have earned grant awards from The V Foundation for Cancer Research, continuing the foundation’s support for innovative cancer research initiatives at VICC.

Read more


Vanderbilt scientists to lead chronic disease research initiative in Vietnam

Oct. 6, 2016—Scientists in the Vanderbilt Epidemiology Center (VEC) and Vanderbilt-Ingram Cancer Center (VICC) have been awarded a grant to plan and develop a Regional Center of Research Excellence in non-communicable diseases in Vietnam.

Read more


In search of new cancer targets

Sep. 9, 2016—Vanderbilt researchers developed a new algorithm to find clinically targetable gene rearrangements in cancers.

Read more


New breast cancer driver

Aug. 26, 2016—Vanderbilt investigators have demonstrated that a certain protein complex drives tumor progression in aggressive breast cancers.

Read more


VIEW MORE EVENTS >